ENDPOINTS

Lyra’s stock soars on Phase 3 success for chronic rhinosinusitis treatment

Jun 2, 2025 - 17:44
 0
Lyra’s stock soars on Phase 3 success for chronic rhinosinusitis treatment
Read More

Tags:

Previous Article

How the birth of a child changes parents' environmental and climate concerns

Next Article

'It's like trying to grow a tree in an oven': Gold mining is sucking the Amazon ...

Related Posts

#ASCO25: Brain cancer cell therapies make early strides

#ASCO25: Brain cancer cell therapies make early strides

Jun 3, 2025  0

Veru’s obesity drug roughly as safe as Wegovy; Keros’ board fight

Veru’s obesity drug roughly as safe as Wegovy; Keros’ b...

May 28, 2025  0

Hinge Health pops 23% as the digital health IPO market reawakens

Hinge Health pops 23% as the digital health IPO market ...

May 22, 2025  0